title: Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirus.
authors.affiliation: Hospital General del Zona 2-A, Instituto Mexicano del Seguro Social, Francisco del Paso y Troncoso, Mexico City, Mexico.
authors.forename: Carlos Manual
authors.initials: CM
authors.lastname: Corona Gutierrez
authors.forename: Alberto
authors.initials: A
authors.lastname: Tinoco
authors.forename: Mario
authors.initials: M
authors.lastname: López Contreras
authors.forename: Tania
authors.initials: T
authors.lastname: Navarro
authors.forename: Patricia
authors.initials: P
authors.lastname: Calzado
authors.forename: Laura
authors.initials: L
authors.lastname: Vargas
authors.forename: Lise
authors.initials: L
authors.lastname: Reyes
authors.forename: Roberto
authors.initials: R
authors.lastname: Posternak
authors.forename: Ricardo
authors.initials: R
authors.lastname: Rosales
mesh_terms: D002985:Clinical Protocols; D015316:Genetic Therapy; D006801:Humans; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000628:therapy*; D011230:Precancerous Conditions / Q000628:therapy*; D014412:Tumor Virus Infections / Q000628:therapy*; D014616:Vaccinia virus / Q000235:genetics